Alexander Anderson
PhD
Principal Investigator, Cancer Immunology Program
👥Biography 个人简介
Alexander Anderson is a leading basic scientist in the TIM-3 checkpoint pathway, having characterized the biology of TIM-3 as an inhibitory molecule on exhausted CD8+ T cells and a regulator of innate immune cell function. His fundamental work on the structure, ligands, and signaling of TIM-3 formed the scientific basis for the clinical development of anti-TIM-3 antibodies including sabatolimab. He has investigated TIM-3 in the context of tumor immunity and hematologic malignancies, and his publications are foundational references for the checkpoint inhibitor field.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Alexander Anderson 的研究动态
Follow Alexander Anderson's research updates
留下邮箱，当我们发布与 Alexander Anderson（Brigham and Women's Hospital / Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment